z-logo
open-access-imgOpen Access
A case of mood disorder with severe side effects of antidepressants in association with resistance to thyroid hormone beta with a THRB mutation
Author(s) -
KomahashiSasaki Hazuki,
YasuiFurukori Norio,
Maehara Ryo,
Hasegawa Chie,
Shimoda Kazutaka
Publication year - 2022
Publication title -
neuropsychopharmacology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.661
H-Index - 13
ISSN - 2574-173X
DOI - 10.1002/npr2.12280
Subject(s) - hormone , mutation , mood , beta (programming language) , endocrinology , medicine , thyroid , association (psychology) , genetics , psychology , biology , psychiatry , psychotherapist , computer science , gene , programming language
Background Although resistance to thyroid hormone beta (RTHβ) is associated with attention‐deficit/hyperactivity disorder, there are few reports of other concomitant mood disorders in individuals with RTHβ. Case presentation A 67‐year‐old woman who had been previously diagnosed with RTHβ (Refetoff syndrome) came to our department as a depressed patient. She was hospitalized twice for depression and treated with antidepressants both times. Paroxetine (37.5 mg/day) treatment during the first hospitalization did not cause any side effects, but treatment with mirtazapine (15 mg/day) and venlafaxine (150 mg/day) during the second hospitalization caused clonus and disturbance of consciousness, and these adverse effects resulted in a prolonged period of hospitalization. Finally, the patient’s symptoms were controlled with quetiapine (75 mg/day). Conclusion Poor tolerability to antidepressants was observed, which may be related to thyroid hormone intolerance. Low doses of quetiapine may contribute to improvements in depression.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here